
### [MONDO:0019217](http://purl.obolibrary.org/obo/MONDO_0019217)
**Label:** disorder of urea cycle metabolism and ammonia detoxification

**Subclasses:** [MONDO:0014332](http://purl.obolibrary.org/obo/MONDO_0014332) (Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency), [MONDO:0009393](http://purl.obolibrary.org/obo/MONDO_0009393) (ornithine translocase deficiency), [MONDO:0016601](http://purl.obolibrary.org/obo/MONDO_0016601) (adult-onset citrullinemia type i), [MONDO:0016600](http://purl.obolibrary.org/obo/MONDO_0016600) (acute neonatal citrullinemia type i), [MONDO:0009376](http://purl.obolibrary.org/obo/MONDO_0009376) (carbamoyl phosphate synthetase i deficiency disease), [MONDO:0009377](http://purl.obolibrary.org/obo/MONDO_0009377) (hyperammonemia due to N-acetylglutamate synthase deficiency), [MONDO:0015991](http://purl.obolibrary.org/obo/MONDO_0015991) (citrullinemia), [MONDO:0008988](http://purl.obolibrary.org/obo/MONDO_0008988) (citrullinemia type i), [MONDO:0008814](http://purl.obolibrary.org/obo/MONDO_0008814) (hyperargininemia), [MONDO:0011717](http://purl.obolibrary.org/obo/MONDO_0011717) (hyperinsulinism-hyperammonemia syndrome), [MONDO:0008815](http://purl.obolibrary.org/obo/MONDO_0008815) (argininosuccinic aciduria), [MONDO:0010703](http://purl.obolibrary.org/obo/MONDO_0010703) (ornithine carbamoyltransferase deficiency), [MONDO:0016603](http://purl.obolibrary.org/obo/MONDO_0016603) (citrullinemia type II), [MONDO:0016602](http://purl.obolibrary.org/obo/MONDO_0016602) (citrin deficiency), [MONDO:0011326](http://purl.obolibrary.org/obo/MONDO_0011326) (citrullinemia, type Ii, adult-onset), [MONDO:0011601](http://purl.obolibrary.org/obo/MONDO_0011601) (neonatal intrahepatic cholestasis due to citrin deficiency), 

**Corr. equiv. classes:** [Orphanet:187](http://www.orpha.net/ORDO/Orphanet_187), [OMIM:605814](http://purl.obolibrary.org/obo/OMIM_605814), [Orphanet:401948](http://www.orpha.net/ORDO/Orphanet_401948), [Orphanet:247573](http://www.orpha.net/ORDO/Orphanet_247573), [Orphanet:247598](http://www.orpha.net/ORDO/Orphanet_247598), [OMIM:237300](http://purl.obolibrary.org/obo/OMIM_237300), [Orphanet:415](http://www.orpha.net/ORDO/Orphanet_415), [OMIM:606762](http://purl.obolibrary.org/obo/OMIM_606762), [OMIM:603471](http://purl.obolibrary.org/obo/OMIM_603471), [OMIM:238970](http://purl.obolibrary.org/obo/OMIM_238970), [Orphanet:90](http://www.orpha.net/ORDO/Orphanet_90), [Orphanet:23](http://www.orpha.net/ORDO/Orphanet_23), [Orphanet:35878](http://www.orpha.net/ORDO/Orphanet_35878), [Orphanet:247582](http://www.orpha.net/ORDO/Orphanet_247582), [OMIM:311250](http://purl.obolibrary.org/obo/OMIM_311250), [Orphanet:247546](http://www.orpha.net/ORDO/Orphanet_247546), [Orphanet:247525](http://www.orpha.net/ORDO/Orphanet_247525), [OMIM:615751](http://purl.obolibrary.org/obo/OMIM_615751), [OMIM:207800](http://purl.obolibrary.org/obo/OMIM_207800), [Orphanet:247585](http://www.orpha.net/ORDO/Orphanet_247585), [OMIM:215700](http://purl.obolibrary.org/obo/OMIM_215700), [Orphanet:927](http://www.orpha.net/ORDO/Orphanet_927), [OMIM:237310](http://purl.obolibrary.org/obo/OMIM_237310), [OMIM:207900](http://purl.obolibrary.org/obo/OMIM_207900), [Orphanet:147](http://www.orpha.net/ORDO/Orphanet_147), [Orphanet:664](http://www.orpha.net/ORDO/Orphanet_664), 

**Class expressions from DL-Learner:**

- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004354](http://purl.obolibrary.org/obo/HP_0004354) (Abnormality of carboxylic acid metabolism) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 57.56%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004337](http://purl.obolibrary.org/obo/HP_0004337) (Abnormality of amino acid metabolism) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 57.56%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 51.65%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004354](http://purl.obolibrary.org/obo/HP_0004354) (Abnormality of carboxylic acid metabolism) 51.65%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004337](http://purl.obolibrary.org/obo/HP_0004337) (Abnormality of amino acid metabolism) 51.65%
- [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) 51.02%
- [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004337](http://purl.obolibrary.org/obo/HP_0004337) (Abnormality of amino acid metabolism) 50.85%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) 50.15%
- [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004354](http://purl.obolibrary.org/obo/HP_0004354) (Abnormality of carboxylic acid metabolism) 49.11%
- [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 48.90%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) 48.90%
- [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004354](http://purl.obolibrary.org/obo/HP_0004354) (Abnormality of carboxylic acid metabolism) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 48.82%
- [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004337](http://purl.obolibrary.org/obo/HP_0004337) (Abnormality of amino acid metabolism) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 48.82%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0004337](http://purl.obolibrary.org/obo/HP_0004337) (Abnormality of amino acid metabolism) 48.82%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0001987](http://purl.obolibrary.org/obo/HP_0001987) (Hyperammonemia) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 48.82%


